Menopause. Stress urinary incontinence. Sexual dysfunction. Dyspareunia.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Women with clinical climacteric symptoms, such as decreased or terminated menses; Women diagnosed with urinary incontinence or who have at least three of the symptoms Urinary incontinence such as nocturia, urgency, urge incontinence, high voiding frequency and enuresis; Women aged> 45 years and 65 years; Women who have had at least one sexual intercourse during the last thirty days;
Exclusion criteria
Exclusion criteria: Women allergic to latex; Women with neurological diseases or with sensory alterations; Use of medications for the treatment of lower urinary tract dysfunctions; Women with previous history of pelvic floor exercises; Women presenting a history of abdominal surgeries in the last six months; Women diagnosed with obstructive or restrictive respiratory disease; No attendance at the evaluation or have more than 25% of absences to the treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The women participating in the study are expected to present a 50% reduction in urinary symptoms as measured by the urinary incontinence assessment questionnaire ICQ-SF.;An increase of at least 30% in the strength of the pelvic floor muscles evaluated using the perfect scheme in women submitted to study. | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected that at least 50% of sexual complaints such as libido, anorgasmia and vaginismus deficits will be evaluated through the FSFI questionnaire.;It is expected an increase of at least 30% of the quality of life scores assessed through the Kings questionnaire. | — |
Countries
Brazil
Contacts
Universidade Federal de Mato Grosso do Sul